UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015049 |
|---|---|
| Receipt number | R000017483 |
| Scientific Title | Phase 2 trial of eribulin/S-1 combination therapy for advanced/recurrent breast cancer |
| Date of disclosure of the study information | 2014/09/05 |
| Last modified on | 2016/06/02 13:15:10 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/09/04 11:14:57 | ||
| 2 | Update | 2016/06/02 13:13:35 | Recruitment status Last follow-up date |
|
| 3 | Update | 2016/06/02 13:15:10 | Name of primary person or sponsor Organization |
